Skip to main content
Premium Trial:

Request an Annual Quote

Mary Tanner, Stephen Oldfield, Jan Hughes, William Murray, Catherine Burzik, Carl Hull, Stephen Kondor, Peter Dansky, John Lisle, and Samraat Raha

Premium

Evotec OAI said last week that Mary Tanner has been elected to the company’s supervisory board. Tanner has 22 years of senior-level management experience in healthcare and consumer products at Lehman Brothers and Bear Stearns, Evotec said. Tanner retired from Bear Stearns in 2004, and founded Life Sciences Partners, a healthcare investment and advisory firm. Tanner obtained a degree from Harvard University in 1973 in philosophy and related fields, Evotec said.


Stephen Oldfield has left his position as vice president of worldwide marketing for Molecular Devices, Inside Bioassays, PGx Reporter’s sister publication, has learned. A company spokesperson declined to provide details regarding Oldfield’s departure. Molecular Devices said it has named Jan Hughes as the new vice president of worldwide marketing. Hughes previously was VP of product development for Molecular Devices’ high-throughput electrophysiology division.


William Murray has been appointed division president, molecular biology at Applied Biosystems, the company said. He takes over for Catherine Burzik, the current president of Applied Biosystems, who had been leading the division since the company announced a restructuring last summer. Murray most recently served as group president of respiratory technologies for Viasys Healthcare. He also has held executive positions at Medtronic. Applied Biosystems also announced other management appointments in the molecular biology division, including naming Carl Hull to the post of vice president and general manager, real-time PCR systems and microarrays. Stephen Kondor was named vice president and general manager, genetic analysis, and Peter Dansky was named senior director and general manager, core PCR and DNA synthesis.


Inpharmatica has appointed John Lisle as chief executive officer, the company said this week. Lisle recently served as chief executive officer of Profile Therapeutics and previously held a variety of commercial roles at GlaxoSmithKline and Astra Zeneca. The current chief executive will stay with the company as chief scientific officer


Samraat Raha, former vice president of GE Healthcare’s CodeLink microarray product line, has joined Agilent Technologies’ Life Science and Chemical Analysis business unit as vice president of field operations for the Americas. Raha manages sales and marketing for the Americas, including all LSCA markets (Integrated Biology, Pharmaceutical Analysis, Chemical Analysis, Consumables & Services). Raha joined Amersham before the company’s acquisition by General Electric and worked there for almost two years before joining Agilent. Previously, he was chief business officer for EraGen of Madison, Wis., and prior to that, he was vice president of discovery services and bioreagents for Incyte Genomics.

Filed under

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.